Moreover, GLP-1R agonists stimulate ANGPTL8 production in human hepatocytes dose-dependently [50], and ANGPTL8 has been described as a novel vitamin D receptor target gene involved in nonalcoholic fatty liver pathogenesis [25]. Here, ANGPTL8 is linked to non-alcoholic fatty liver.